Answers are grounded in this paper and cite their sources.
Loss of normal beta-cell function, rather than total mass, is increasingly considered to be the major driver for impaired insulin secretion in diabetes. Better understanding of the role of oxidative changes, its modulation by genes involved in disease risk, and effects on beta-cell identity may facilitate the development of new therapeutic strategies to this disease. Antioxid. Redox Signal. 26, 501-518.
No takes yet. Share an insight, caveat, or question.
Gerber et al. (2016) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: